{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:01:36Z","timestamp":1787169696531,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>BK polyomavirus-associated hemorrhagic cystitis (BKPyV-HC) is a well-recognized infective complication of hematopoietic cell transplant (HCT) with increased organ dysfunction and mortality. This study was performed to describe the local incidence, risk factors, and outcomes of BKPyV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective case\u2013control study was conducted between 2007 and 2016 from a tertiary hospital in South India. We identified HCT recipients diagnosed with BKPyV-HC and compared them with recipients over the same period who did not develop BK virus infection matched for age, sex, diagnosis, and donor type. We collected data from central electronic medical records and databases maintained in the departments of hematology and virology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Over the study period, 1276 transplants were performed, of which 262 patients (20.5%) developed HC and 105 (8.2%) were BKPyV-positive. Grade 3 HC was most commonly (57.1%) seen, and the median time to develop BKPyV-HC was 35 (range 0\u2013858) days. Survival was significantly lower in the cases (42.9% vs. 61%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). On univariate analysis, the protective effect of nonmyeloablative conditioning (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04), residual disease at the time of transplant in malignant conditions (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), lower CD34 dose (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.006), presence of acute graft versus host disease (GVHD,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), reactivation of cytomegalovirus infection (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and presence of bacterial urinary tract infection (UTI) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) were significant factors. Multivariate logistic regression confirmed the presence of acute GVHD (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.041), bacterial UTI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and residual disease (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009) at HCT as significant risk factors for BKPyV-HC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our study affirms the homogeneity of BKPyV-HC disease in low- and middle-income HCT settings with prior reports and the need for therapeutic strategies to reduce its resultant mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jgid.jgid_139_21","type":"journal-article","created":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T04:27:33Z","timestamp":1646022453000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["BK Polyomavirus Hemorrhagic Cystitis in Hematopoietic Cell Transplant Recipients"],"prefix":"10.4103","volume":"14","author":[{"given":"Sharon Anbumalar","family":"Lionel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aby","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha Mary","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20240828","first-page":"12","article-title":"ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients","volume":"73","author":"Cesaro","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R2-4-20240828","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/sj.bmt.1705909","article-title":"A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation","volume":"41","author":"Cesaro","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R3-4-20240828","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3324\/haematol.2009.016758","article-title":"Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type","volume":"95","author":"Silva Lde","year":"2010","journal-title":"Haematologica"},{"key":"R4-4-20240828","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R5-4-20240828","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.4103\/1319-2442.248313","article-title":"BK virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India","volume":"29","author":"Gupta","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R7-4-20240828","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41409-020-01092-x","article-title":"Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: Impact of HLA donor matching","volume":"56","author":"Irene","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"R8-4-20240828","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"R9-4-20240828","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0090-4295(82)90633-1","article-title":"Prevention of cyclophosphamide-induced hemorrhagic cystitis","volume":"20","author":"Droller","year":"1982","journal-title":"Urology"},{"key":"R10-4-20240828","first-page":"517","article-title":"Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC\/BCR\/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists","volume":"34","author":"Dati","year":"1996","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"R11-4-20240828","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/ijmm.IJMM_18_54","article-title":"BK virus characterisation among HIV-1-Infected individuals and its association with immunosuppression","volume":"36","author":"Jagannath","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"R12-4-20240828","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","article-title":"How we treat cytomegalovirus in hematopoietic cell transplant recipients","volume":"113","author":"Boeckh","year":"2009","journal-title":"Blood"},{"key":"R13-4-20240828","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bbmt.2007.08.047","article-title":"A scheme for defining cause of death and its application in the T cell depletion trial","volume":"13","author":"Copelan","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-4-20240828","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.bmt.1704274","article-title":"Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation","volume":"32","author":"Asano","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R15-4-20240828","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-019-0244-7","article-title":"A correlation study of BK Polyoma virus infection and prostate cancer among Sudanese patients \u2013 Immunofluorescence and molecular based case-control study","volume":"14","author":"Gorish","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"R16-4-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/1607845412Y.0000000010","article-title":"Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: Retrospective analysis in a single institution","volume":"17","author":"Arai","year":"2012","journal-title":"Hematology"},{"key":"R17-4-20240828","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bmt.1704966","article-title":"Immune restoration following hematopoietic stem cell transplantation: An evolving target","volume":"35","author":"Auletta","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R18-4-20240828","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/sj.bmt.1705139","article-title":"Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: A changing paradigm","volume":"36","author":"Leung","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R20-4-20240828","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","article-title":"Platelets and innate immunity","volume":"67","author":"Semple","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"R21-4-20240828","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1182\/bloodadvances.2019000802","article-title":"Presentation of BK polyomavirus-associated hemorrhagic cystitis after allogeneic hematopoietic cell transplantation","volume":"4","author":"Imlay","year":"2020","journal-title":"Blood Adv"},{"key":"R22-4-20240828","doi-asserted-by":"crossref","first-page":"e13601","DOI":"10.1111\/tid.13601","article-title":"Risk factors of BK viral hemorrhagic cystitis in allogenic hematopoietic stem cell transplantation","volume":"23","author":"Kaphan","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R23-4-20240828","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.bbmt.2010.12.700","article-title":"Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients","volume":"17","author":"Miller","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R24-4-20240828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0166-3542(88)90004-6","article-title":"Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase","volume":"9","author":"Portolani","year":"1988","journal-title":"Antiviral Res"},{"key":"R25-4-20240828","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2215\/CJN.04230413","article-title":"Efficacy of levofloxacin in the treatment of BK viremia: A multicenter, double-blinded, randomized, placebo-controlled trial","volume":"9","author":"Lee","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-4-20240828","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, Human herpesvirus 6, Cytomegalovirus, Epstein-barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"key":"R27-4-20240828","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/ccr3.3246","article-title":"BK virus-induced nephritis and cystitis after matched unrelated donor stem cell transplantation: A case report","volume":"8","author":"Gelbrich","year":"2020","journal-title":"Clin Case Rep"},{"key":"R28-4-20240828","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jmb.2018.06.024","article-title":"Virus-receptor interactions: The key to cellular invasion","volume":"430","author":"Maginnis","year":"2018","journal-title":"J Mol Biol"},{"key":"R29-4-20240828","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","article-title":"Sialic acids in human health and disease","volume":"14","author":"Varki","year":"2008","journal-title":"Trends Mol Med"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_139_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:11:20Z","timestamp":1787166680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jgid.jgid_139_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jgid.jgid_139_21","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}